Drug Trial Radar · NCT00323817
To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia
Last checked: Nov 19, 2026Latest source record: May 28, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
282
Planned (sponsor's estimate)
Start
Apr 2006
Primary completion
Apr 2009
Study completion Oct 2009
Sponsor
- Lead sponsor
- Zeria PharmaceuticalIndustry
- Sponsor type
- Industry
- First posted
- May 10, 2006
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy and safety of Z-338 in subjects with Functional Dyspepsia
Conditions
- Functional Dyspepsia
Interventions
Z-338Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Global subject Outcome AssessmentTime frame: 12 month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Leuven University
Leuven, Belgium
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.